Biotech Deal Toys

Custom financial tombstone recognizing a follow-on offering by Turning Point Therapeutics. Turning Point is a clinical-stage biopharmaceutical company focused on oncology therapies. (9ALJ524)

Lucite tombstone commemorating a public offering of stock by Achieve Life Sciences. Achieve is engaged in the development and cytisinicline, a plant-based alkaloid used for smoking cessation and nicotine addiction. (20AMF022)

(20AKL59)

(20AKL59)

Financial tombstone marking the acquisition of Quadrant Scientific. The firm specializes in chemical and microbiological testing and environmental monitoring services for the pharmaceutical, biotechnology, and medical device sectors. (20ALJ029)

Custom Lucite tombstone commemorating the acquisition of Quadrants Scientific, a San Diego-based chemical and microbiological testing laboratory. (20ALJ029)

Crystal deal toy, featuring 3D laser etching, commemorating a private placement by Nordic Nanovector. The Norwegian life sciences firm develops drugs for the treatment of cancer. (9LJW269)

Lucite deal tombstone marking private placements by Sonic Healthcare. The diagnostic laboratory medicine firm is headquartered in Sydney, Australia. (9AJH188)

Lucite deal toy commemorating several U.S. private placements by Australia-based Sonic Healtcare. (9AJH188)

Side View of crystal deal tombstone commemorating a private placement by Aytu Bioscience. The commercial-stage pharmaceutical company is based in Englewood, Colorado. (9AMF327)

Crystal deal toy marking a private placement by Colorado-based pharmaceutical firm Aytu Bioscience. (9AMF327)

DNA-themed Lucite tombstone marking the acquisition of a majority stake in Spanish biotech firm Igenomix. (9LSS177)

Lucite deal toy celebrating the acquisition by Swedish fund EQT of Igenomix, a medical testing laboratory specializing in reproductive genetic services. (9LSS177)

Lucite deal tombstone marking the sale of Igenomix by European private equity fund Charme Capital Partners. Headquartered in Valencia, Spain, Igenomix is a biotechnology company focused on women's health and reproductive genetics. (9LSS177)

Custom Lucite commemorating the acquisition of Igenomix, a Spanish provider of genetic testing services for reproductive health patients. (9LSS177)

Custom crystal tombstone marking a private placement by Rezolute, a California-based clinical stage biopharmaceutical firm. (9ALJ067)

Logo-themed crystal tombstone commemorating a private placement by NovaBay Pharmaceuticals. The biopharmaceutical company is based Emeryville, California. (9AMF250)

Custom Lucite tombstone commemorating Series B funding for D&D Pharmatech. The firm develops therapeutics for dementia, Alzheimer's disease, and Parkinson's disease. (9AJH103)

Custom Lucite deal toy commemorating Series B funding for Pharmatech, the developer of a drug therapy for dementia. (9AJH103)

Side view of custom crystal tombstone recognizing a follow-on offering of common stock by Gritstone, a California-based biotech firm. (9ALJ202)

Crystal deal toy commemorating a follow-on offering by Gritstone Oncology, a clinical-stage biotechnology firm focused on cancer immunotherapies. Goldman Sachs and Cowen and Company acted as joint book-running managers for the offering. (9ALJ202)

Custom crystal marking financing provided by TPG Sixth Street Partners for a clinical study focused on ovarian cancer. (9ALJ233)

Custom crystal tombstone commemorating clinical trial financing provided for biopharmaceutical company, Clovis Oncology.  The clinical trial sponsored by Clovis involves an ovarian cancer study. (9ALJ233)

Custom Lucite, with an embedded champagne cork, celebrating the approval by the Food and Drug Administration (FDA) of the obesity treatment Plenity. Plenity was developed by Boston-based biotech firm Gelesis. (9AMF149)

Custom deal toy recognizing the acquisition of Ultimate Labs by Colorado-based Infinity Laboratories, a chemical and microbiological contract laboratory. (9ALJ145)

Custom Lucite deal toy commemorating the acquisition of San Diego-based Ultimate Labs, a testing laboratory for the pharmaceutical, biotechnology, medical device, and food industries. (9ALJ145)

Custom crystal award featuring a 3-D etch of a DNA strand. (9ACJ007)

Custom Lucite deal toy marking equity financing for DisperSol Technologies, a Texas-based drug development firm. (9ACJ018)

Custom Lucite tombstone commemorating equity financing for Georgetown, Texas-based biotech firm DisperSol Technologies. (9ACJ018)

Custom crystal tombstone celebrating a second close of Series A financing for Fusion Pharmaceuticals. The Hamilton, Ontario-based firm is focused on radiotherapeutics for treating cancer. (8ALJ479)